Higher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.
Jill E. Bagalman, MSW
Advertisement
Articles by Jill E. Bagalman, MSW
Advertisement
Latest Updated Articles
- Impact of Cost-Sharing on Treatment Augmentation in Patients With Depression
Published: January 16th 2012 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices
2
FDA Approves Lumateperone as Add-On Therapy for Major Depressive Disorder
3
CMS Announces GENEROUS Model to Lower Medicaid Drug Prices
4
Preventing Tomorrow’s High-Cost Claims: The Rising-Risk Patient Opportunity in Medicaid
5
